Catalyst Wire Dossier Catalyst Wire Dossier

SurgiMend

· Integra LifeSciences Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SurgiMend, covering 2017-01-10 to 2017-01-10. Get the full timeline:

Most recent: Clinical Trial Update: SurgiMend in Two-stage Implant-based Breast Reconstruction in Patients With Pre-Mastectomy Radiotherapy [NA]

See pricing